Remlifanserin

DB21707ExperimentalSmall molecule

Remlifanserin is a small molecule drug. The usage of the INN stem '-anserin' in the name indicates that Remlifanserin is a serotonin receptor antagonist. Remlifanserin has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 2A
Curator reviewed
Formula / weight: C₂₄H₂₉F₂N₃O₂ · 429.512 g/mol (avg)

Resolves to

Compound

UNIIH4L2AF2XB7CAS2289704-13-6ChEMBLCHEMBL6068071ChEBI759989PubChem137520242

Structure

InChIKeyUYRCLXJMWZFKDG-UHFFFAOYSA-NSMILESCN1CCC(CC1)N(CC1=C(F)C=C(F)C=C1)C(=O)NCC1=CC=C(OC2CC2)C=C1

Targets

P28223HTR2A

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Remlifanserin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account